A report on the status of vaccination in Europe

Sheikh S, Biundo E, Courcier S, Damm O, Launay O, Maes E, Marcos C, Matthews S, Meijer C, Poscia A, Postma M, et al. (2018)
VACCINE 36(33): 4979-4992.

Zeitschriftenaufsatz | Veröffentlicht| Englisch
 
Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Autor/in
Sheikh, Shazia; Biundo, Eliana; Courcier, Soizic; Damm, OliverUniBi; Launay, Odile; Maes, Edith; Marcos, Camelia; Matthews, Sam; Meijer, Catherina; Poscia, Andrea; Postma, Maarten; Saka, Omer
Alle
Abstract / Bemerkung
Vaccine policy, decision processes and outcomes vary widely across Europe. The objective was to map these factors across 16 European countries by assessing (A) national vaccination strategy and implementation, (B) attributes of healthcare vaccination systems, and (C) outcomes of universal mass vaccination (UMV) as a measure of how successful the vaccination policy is. A. Eleven countries use standardised assessment frameworks to inform vaccine recommendations. Only Sweden horizon scans new technologies, uses standard assessments, systematic literature and health economic reviews, and publishes its decision rationale. Time from European marketing authorisation to UMV implementation varies despite these standard frameworks. Paediatric UMV recommendations (generally government-funded) are relatively comparable, however only influenza vaccine is widely recommended for adults. B. Fourteen countries aim to report annually on national vaccine coverage rates (VCRs), as well as have target VCRs per vaccine across different age groups. Ten countries use either electronic immunisation records or a centralised registry for childhood vaccinations, and seven for other age group vaccinations. C. National VCRs for infant (primary diphtheria tetanus pertussis (DTP)), adolescent (human papillomavirus (HPV)) and older adult (seasonal influenza) UMV programmes found ranges of: 89.1% to 98.2% for DTP-containing vaccines, 5% to 85.9% for HPV vaccination, and 4.3% to 71.6% for influenza vaccine. Regarding reported disease incidence, a wide range was found across countries for measles, mumps and rubella (in children), and hepatitis B and invasive pneumococcal disease (in all ages). These findings reflect an individual approach to vaccination by country. High VCRs can be achieved, particularly for paediatric vaccinations, despite different approaches, targets and reporting systems; these are not replicated in vaccines for other age groups in the same country. Additional measures to improve VCRs across all age groups are needed and could benefit from greater harmonisation in target setting, vaccination data collection and sharing across EU countries. (C) 2018 GlaxoSmithKline Biologicals SA. Published by Elsevier Ltd.
Stichworte
Vaccination; Europe; Policy; Decision-making; Coverage; Performance
Erscheinungsjahr
2018
Zeitschriftentitel
VACCINE
Band
36
Ausgabe
33
Seite(n)
4979-4992
ISSN
0264-410X
eISSN
1873-2518
Page URI
https://pub.uni-bielefeld.de/record/2931114

Zitieren

Sheikh S, Biundo E, Courcier S, et al. A report on the status of vaccination in Europe. VACCINE. 2018;36(33):4979-4992.
Sheikh, S., Biundo, E., Courcier, S., Damm, O., Launay, O., Maes, E., Marcos, C., et al. (2018). A report on the status of vaccination in Europe. VACCINE, 36(33), 4979-4992. doi:10.1016/j.vaccine.2018.06.044
Sheikh, S., Biundo, E., Courcier, S., Damm, O., Launay, O., Maes, E., Marcos, C., Matthews, S., Meijer, C., Poscia, A., et al. (2018). A report on the status of vaccination in Europe. VACCINE 36, 4979-4992.
Sheikh, S., et al., 2018. A report on the status of vaccination in Europe. VACCINE, 36(33), p 4979-4992.
S. Sheikh, et al., “A report on the status of vaccination in Europe”, VACCINE, vol. 36, 2018, pp. 4979-4992.
Sheikh, S., Biundo, E., Courcier, S., Damm, O., Launay, O., Maes, E., Marcos, C., Matthews, S., Meijer, C., Poscia, A., Postma, M., Saka, O., Szucs, T., Begg, N.: A report on the status of vaccination in Europe. VACCINE. 36, 4979-4992 (2018).
Sheikh, Shazia, Biundo, Eliana, Courcier, Soizic, Damm, Oliver, Launay, Odile, Maes, Edith, Marcos, Camelia, Matthews, Sam, Meijer, Catherina, Poscia, Andrea, Postma, Maarten, Saka, Omer, Szucs, Thomas, and Begg, Norman. “A report on the status of vaccination in Europe”. VACCINE 36.33 (2018): 4979-4992.

4 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

HPV infection in semen: results from a new molecular approach.
Capra G, Schillaci R, Bosco L, Roccheri MC, Perino A, Ragusa MA., Epidemiol Infect 147(), 2019
PMID: 31063107
Parental Knowledge about Meningococcal Disease and Vaccination Uptake among 0⁻5 years Old Polish Children.
Drozd-Dąbrowska M, Topczewska K, Korzeń M, Sałacka A, Ganczak M., Int J Environ Res Public Health 16(2), 2019
PMID: 30669259
Prevalence of HPV Genotypes in South Europe: Comparisons between an Italian and a Turkish Unvaccinated Population.
Schettino MT, De Franciscis P, Schiattarella A, La Manna V, Della Gala A, Caprio F, Tammaro C, Ammaturo FP, Guler T, Yenigün EH., J Environ Public Health 2019(), 2019
PMID: 31236119
Mandatory vaccination: suited to enhance vaccination coverage in Europe?
Holzmann H, Wiedermann U., Euro Surveill 24(26), 2019
PMID: 31266587

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 30037416
PubMed | Europe PMC

Suchen in

Google Scholar